MktsMarkets

Sunshine Biopharma Inc.
NASDAQ: SBFMKey statistics
SBFM News
Stories mentioning SBFM from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 8,089 | 8,578 | 9,417 | 9,410 | 8,901 | 9,595 | 8,435 | 9,303 |
| Cost of Goods Sold | 5,908 | 5,548 | 6,344 | 5,987 | 6,171 | 6,501 | 5,569 | 6,947 |
| Gross Profit | 2,181 | 3,029 | 3,074 | 3,423 | 2,730 | 3,094 | 2,866 | 2,356 |
| Operating Expenses | ||||||||
| Research & Development | 32.00 | 74.00 | 119.00 | 196.00 | 215.00 | 150.00 | 126.00 | 436.00 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (1,396) | (1,789) | (1,087) | (2,055) | (1,296) | (2,087) | (1,106) | (1,268) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (1,244) | (1,733) | (1,021) | (1,980) | (1,220) | (2,287) | (983.00) | (838.00) |
| Tax Provision | 0.00 | 408.00 | (137.00) | (209.00) | (40.00) | (128.00) | 215.00 | (344.00) |
| Net Income (Loss) | (1,244) | (2,140) | (884.00) | (1,771) | (1,180) | (2,158) | (1,198) | (494.00) |
| Earnings Per Share (Basic) | (0.25) | (0.51) | (0.19) | (0.39) | (0.44) | (3.07) | (0.94) | (9.94) |
| Earnings Per Share (Diluted) | (0.82) | (0.44) | (3.07) | (43.48) | ||||
| Weighted Average Shares Outstanding (Basic) | 4,906 | 4,157 | 4,556 | 4,496 | 2,703 | 702.00 | 1,268 | 50.00 |
| Weighted Average Shares Outstanding (Diluted) | 3,605 | 2,703 | 702.00 | 1,268 | 41.00 | |||
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About SBFM
Sunshine Biopharma Inc. (NASDAQ: SBFM) is a stock listed on the Nasdaq Stock Market under the ticker symbol SBFM. It last traded at $2.71 (Nov 6, 2026, 4:00 PM ET), down 2.9% on the day. That gives Sunshine Biopharma a market capitalisation of $2.1M.
Over the past 52 weeks SBFM has traded between $2.53 and $464.00.
Revenue for the quarter ended Mar 31, 2026 was $8.1M; a net loss of $1.2M. Revenue was down 9.1% from $8.9M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $8.1M | -$1.2M | -15.4% |
| Dec 31, 2025 | $8.6M | -$2.1M | -24.9% |
| Sep 30, 2025 | $9.4M | -$884.0K | -9.4% |
| Jun 30, 2025 | $9.4M | -$1.8M | -18.8% |
From Sunshine Biopharma’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…